Here are five insights:
1. Dan Altman, MD, Nestor Tomycz, MD, and Terrence Julien, MD, implanted the patient with the Neuro-Spinal Scaffold 21 hours following spinal cord injury.
2. Dr. Julien, co-director of minimally invasive spine surgery, serves as the site’s principal investigator.
3. The INSPIRE study now has 16 patients in follow up.
4. Allegheny General Hospital is a part of the Allegheny Health Network, also in Pittsburgh.
5. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
More articles on devices:
FDA approves ConforMIS iTotal Hip system: 5 key notes
Camber Spine Technologies appoints 2 new area sales directors: 4 things to know
Global Health Care Exchange honors Mizuho OSI as U.S. Healthcare Supplier of the Year: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
